Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jan 15, 2024 8:34am
66 Views
Post# 35826542

RE:Volume AEZS NASDAQ

RE:Volume AEZS NASDAQA big goal for investors is to get in before the crowd, fossi. I've said many times that we are early and before key and strategic milestones. The question is what happens if the key milestones are hit. What happens when AEZS's diagnostic data for the most important markets(children) is released? What happens if FDA and European approval to sell the test is given? What happens if AEZS signs a licensing deal(upfront, milestone payments, royalties)? What happens if PGX is successfully commissioned at 5X and 10X scale-up this year; including with Natex? What happens if a PGX licensing deal is signed upon successful scale-up? What happens when safety/tolerability, preliminary efficacy for the avenanthramide clinical trial is released? What happens if clinical trial 'go' decisions happen for fibrosis, wound healing, AIM Biologicals? What happens if licensing deals occur for the aveanthramide pill, wound healing program, and for AIM Biologicals? What happens if CZO's main client returns, the new powder formulations of avenanthramide and oat beta glucan are released, and sales of malted avenanthramide into the neutraceutical market begin? The merger puts in place capital to pursue CZO's plans for significant growth the news release says. There's  a lot about to happen given the milestones lined up. Given the C$100 million target price for AEZS from H.C. Wainwright, and that it is a merger of equals it could be seen as a capital raise at $1.25 per share of CZO without warrants and with other benefits. That could sure beat a financng with warrants, etc. It is seen as the best path forward according to Ronnie Miller.

  


fossi_2002 wrote: Is this a market for investors?

Time ET Ex Price Change Volume
17:47:51 Q 2.31 0.19 1
17:47:19 Q 2.09 -0.03 1
16:15:38 Q 2.20 0.08 300
16:06:03 Q 2.33 0.21 10
16:02:24 Q 2.33 0.21 1
16:00:01 Q 2.05 -0.07 2
15:59:52 Q 2.06 -0.06 98
15:59:52 Q 2.05 -0.07 2
15:59:51 Q 2.06 -0.06 2
15:58:36 Q 2.08 -0.04 100
Recent Trades - Last 10 of 93



<< Previous
Bullboard Posts
Next >>